<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jnutbio.com/?rss=yes"><title>The Journal of Nutritional Biochemistry</title><description>The Journal of Nutritional Biochemistry RSS feed: Current Issue.    
 
 
 
Devoted to advancements in nutritional sciences, the  The Journal of Nutritional Biochemistry  
presents experimental nutrition research as it relates to: biochemistry, neurochemistry, molecular biology, toxicology, physiology and 
pharmacology. Rigorous reviews by an international editorial board of distinguished scientists ensure publication of the most current 
and key research being conducted in nutrition at the cellular, animal and human level. In addition to its monthly features of critical 
reviews and research communications, the  The Journal of Nutritional Biochemistry  also periodically publishes emerging issues, 
conference summaries, experimental methods, symposium reports, metabolic pathways, and short communications.   </description><link>http://www.jnutbio.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:issn>0955-2863</prism:issn><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:publicationDate>June 2012</prism:publicationDate><prism:copyright> © 2012 Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286312001167/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000787/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000799/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000817/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000830/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000842/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000866/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000878/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631100088X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000891/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000908/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631100091X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000921/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000933/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000945/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000957/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000969/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000970/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000982/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311000994/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311001008/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311001136/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286311001240/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jnutbio.com/article/PIIS0955286312001167/abstract?rss=yes"><title>Table of Contents</title><link>http://www.jnutbio.com/article/PIIS0955286312001167/abstract?rss=yes</link><description></description><dc:title>Table of Contents</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0955-2863(12)00116-7</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2012-06-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2012-06-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>i</prism:startingPage><prism:endingPage>ii</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000787/abstract?rss=yes"><title>Tools for the identification of bioactives impacting the metabolic syndrome: screening of a botanical extract library using subcutaneous and visceral human adipose-derived stem cell-based assays</title><link>http://www.jnutbio.com/article/PIIS0955286311000787/abstract?rss=yes</link><description>Abstract: Plant extracts continue to represent an untapped source of renewable therapeutic compounds for the treatment and prevention of illnesses including chronic metabolic disorders. With the increase in worldwide obesity and its related morbidities, the need for identifying safe and effective treatments is also rising. As such, use of primary human adipose-derived stem cells represents a physiologically relevant cell system to screen for bioactive agents in the prevention and treatment of obesity and its related complications. By using these cells in a primary screen, the risk and cost of identifying artifacts due to interspecies variation and immortalized cell lines is eliminated. We demonstrate that these cells can be formatted into 384-well high throughput screens to rapidly identify botanical extracts that affect lipogenesis and lipolysis. Additionally, counterscreening with human primary stem cells from distinct adipose depots can be routinely performed to identify tissue specific responses. In our study, over 500 botanical extracts were screened and 16 (2.7%) were found to affect lipogenesis and 4 (0.7%) affected lipolysis.</description><dc:title>Tools for the identification of bioactives impacting the metabolic syndrome: screening of a botanical extract library using subcutaneous and visceral human adipose-derived stem cell-based assays</dc:title><dc:creator>Benjamin M. Buehrer, David J. Duffin, Y. Renee Lea-Currie, David Ribnicky, Ilya Raskin, Jacqueline M. Stephens, William T. Cefalu, Jeffrey M. Gimble</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-05-05</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-05-05</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>519</prism:startingPage><prism:endingPage>525</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000799/abstract?rss=yes"><title>Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice</title><link>http://www.jnutbio.com/article/PIIS0955286311000799/abstract?rss=yes</link><description>Abstract: Epigallocatechin-3-gallate (EGCG) from green tea has been indicated to have anti-inflammatory activity. However, most of the evidence is in vitro studies in which EGCG is often added at levels unachievable by oral intake. With few exceptions, in vivo studies along this line have been conducted in animal models of diseases, and the results are inconclusive. In this study, we fed C57BL/6 mice a diet containing 0%, 0.15%, 0.3% or 1% (w/w) EGCG for 6 weeks. Contrary to the assumption that EGCG would reduce inflammatory response, mice fed 0.15% and 0.3% EGCG diet exhibited no change while those fed 1% EGCG diet produced more proinflammatory cytokines tumor necrosis factor-α, interleukin (IL)-6, and IL-1β and lipid inflammatory mediator prostaglandin E2 in their splenocytes and macrophages (MΦ) and less IL-4 in splenocytes. Spleens from the mice fed 1% EGCG diet also had higher proportions of regulatory T cells, MΦ, natural killer (NK) cells and NKT cells compared to those from mice fed the other diets. These results suggest that high intake of EGCG may induce a proinflammatory response, and this change may be associated with a disturbed homeostasis of immune cells involving changes in both function and number of specific immune cell populations. While the mechanisms and clinical significance for this effect of EGCG remain to be investigated further, these data suggest the need for defining accurate EGCG dose limits to induce an anti-inflammatory effect since current data indicate that higher doses would produce an inflammatory response.</description><dc:title>Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice</dc:title><dc:creator>Munkyong Pae, Zhihong Ren, Mohsen Meydani, Fu Shang, Donald Smith, Simin Nikbin Meydani, Dayong Wu</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-06-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-06-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>526</prism:startingPage><prism:endingPage>531</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000817/abstract?rss=yes"><title>Estrogen status alters tissue distribution and metabolism of selenium in female rats</title><link>http://www.jnutbio.com/article/PIIS0955286311000817/abstract?rss=yes</link><description>Abstract: A reported association between estrogen and selenium status may be important in the regulation of selenium metabolism. In this study, the effect of estrogen status on the metabolism of orally administered 75Se-selenite and tissue selenium status was investigated. Female Sprague–Dawley rats were bilaterally ovariectomized at 7 weeks of age and implanted with either a placebo pellet (OVX) or pellet containing estradiol (OVX+E2), or were sham operated (Sham). At 12 weeks of age, 60 µCi of 75Se as selenite was orally administered to OVX and OVX+E2 rats. Blood and organs were collected 1, 3, 6 and 24 h after dosing. Estrogen status was associated with time-dependent differences in distribution of 75Se in plasma, red blood cell (RBC), liver, heart, kidney, spleen, brain and thymus and incorporation of 75Se into plasma selenoprotein P (Sepp1) and glutathione peroxidase (GPx). Estrogen treatment also significantly increased selenium concentration and GPx activity in plasma, liver and brain, selenium concentration in RBC and hepatic Sepp1 and GPx1 messenger RNA. These results suggest that estrogen status affects tissue distribution of selenium by modulating Sepp1, as this protein plays a central role in selenium transport.</description><dc:title>Estrogen status alters tissue distribution and metabolism of selenium in female rats</dc:title><dc:creator>Xiaodong Zhou, Anne M. Smith, Mark L. Failla, Kristina E. Hill, Zhongtang Yu</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-06-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-06-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>532</prism:startingPage><prism:endingPage>538</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000830/abstract?rss=yes"><title>Lipid alterations in human colon epithelial cells induced to differentiation and/or apoptosis by butyrate and polyunsaturated fatty acids</title><link>http://www.jnutbio.com/article/PIIS0955286311000830/abstract?rss=yes</link><description>Abstract: The present study highlights the important association between lipid alterations and differentiation/apoptotic responses in human colon differentiating (FHC) and nondifferentiating (HCT-116) cell lines after their treatment with short-chain fatty acid sodium butyrate (NaBt), polyunsaturated fatty acids (PUFAs), and/or their combination. Our data from GC/MS and LC/MS/MS showed an effective incorporation and metabolization of the supplemented arachidonic acid (AA) or docosahexaenoic acid (DHA), resulting in an enhanced content of the respective PUFA in individual phospholipid (PL) classes and an altered composition of the whole cellular fatty acid spectrum in both FHC and HCT-116 cells. We provide novel evidence that NaBt combined with PUFAs additionally modulated AA and DHA cellular levels and caused their shift from triacylglycerol to PL fractions. NaBt increased, while AA, DHA and their combination with NaBt decreased endogenous fatty acid synthesis in FHC but not in HCT-116 cells. Fatty acid treatment also altered membrane lipid structure, augmented cytoplasmic lipid droplet accumulation, reactive oxygen species (ROS) production and dissipation of the mitochondrial membrane potential. All these parameters were significantly enhanced by combined NaBt/PUFA treatment, but only in FHC cells was this accompanied by highly increased apoptosis and suppressed differentiation. Moreover, the most significant changes of ROS production, differentiation and apoptosis among the parameters studied, the highest effects of combined NaBt/PUFA treatment and a lower sensitivity of HCT-116 cells were confirmed using two-way ANOVA. Our results demonstrate an important role of fatty acid-induced lipid alterations in the different apoptotic/differentiation response of colon cells with various carcinogenic potential.</description><dc:title>Lipid alterations in human colon epithelial cells induced to differentiation and/or apoptosis by butyrate and polyunsaturated fatty acids</dc:title><dc:creator>Jiřina Hofmanová, Miroslav Ciganek, Josef Slavík, Alois Kozubík, Lenka Stixová, Alena Vaculová, Ladislav Dušek, Miroslav Machala</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>539</prism:startingPage><prism:endingPage>548</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000842/abstract?rss=yes"><title>Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis</title><link>http://www.jnutbio.com/article/PIIS0955286311000842/abstract?rss=yes</link><description>Abstract: Objective: Abdominal aortic aneurysm (AAA) is a chronic vascular disease characterized by medial degradation and inflammation. No medical approaches have been validated for treating AAA, and therapeutic options are limited to regular surveillance leading to surgical intervention. This study aimed to investigate whether administration of Chinese red yeast rice (Monascus purpureus; RYR) suppressed angiotensin II (AngII)-induced AAA and atherosclerosis.Methods and Results: Apolipoprotein E-deficient male mice fed a normal diet were administered either RYR extract (200 mg/kg/day) or vehicle by gavage for 1 week before initiating AngII infusion (1000 ng/kg/min) via subcutaneous osmotic pumps for 28 days. Red yeast rice extract administration significantly suppressed AngII-induced expansion of suprarenal diameter and area (P&lt;.05). Furthermore, RYR extract significantly reduced atherosclerotic lesion areas in both the intima of aortic arches and cross sections of aortic roots (P&lt;.05). These effects were associated with reductions of serum total cholesterol, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, matrix metalloproteinase (MMP) 2 and increases of serum macrophage migration inhibitory factor, but no changes in serum interleukin (IL) 1α, IL-6, monocyte chemoattractant protein 1, MMP-9 and expression of MMP-2 and MMP-9 in aortic walls.Conclusions: This study demonstrated that RYR extract administration suppressed AngII-induced AAA and atherosclerosis associated with regulating inflammation responses independent of lipid-lowering effects. Red yeast rice may have preventive potential for patients with AAA.</description><dc:title>Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis</dc:title><dc:creator>Xiaojie Xie, Yifan Wang, Songzhao Zhang, Guidi Zhang, Yinchuan Xu, Honghao Bi, Alan Daugherty, Jian-an Wang</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>549</prism:startingPage><prism:endingPage>556</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000866/abstract?rss=yes"><title>Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis</title><link>http://www.jnutbio.com/article/PIIS0955286311000866/abstract?rss=yes</link><description>Abstract: Propolis is a polyphenol-rich resinous substance extensively used to improve health and prevent diseases. The effects of polyphenols from different sources of propolis on atherosclerotic lesions and inflammatory and angiogenic factors were investigated in LDL receptor gene (LDLr−/−) knockout mice. The animals received a cholesterol-enriched diet to induce the initial atherosclerotic lesions (IALs) or advanced atherosclerotic lesions (AALs). The IAL or AAL animals were divided into three groups, each receiving polyphenols from either the green, red or brown propolis (250 mg/kg per day) by gavage. After 4 weeks of polyphenol treatment, the animals were sacrificed and their blood was collected for lipid profile analysis. The atheromatous lesions at the aortic root were also analyzed for gene expression of inflammatory and angiogenic factors by quantitative real-time polymerase chain reaction and immunohistochemistry. All three polyphenol extracts improved the lipid profile and decreased the atherosclerotic lesion area in IAL animals. However, only polyphenols from the red propolis induced favorable changes in the lipid profiles and reduced the lesion areas in AAL mice. In IAL groups, VCAM, MCP-1, FGF, PDGF, VEGF, PECAM and MMP-9 gene expression was down-regulated, while the metalloproteinase inhibitor TIMP-1 gene was up-regulated by all polyphenol extracts. In contrast, for advanced lesions, only the polyphenols from red propolis induced the down-regulation of CD36 and the up-regulation of HO-1 and TIMP-1 when compared to polyphenols from the other two types of propolis. In conclusion, polyphenols from propolis, particularly red propolis, are able to reduce atherosclerotic lesions through mechanisms including the modulation of inflammatory and angiogenic factors.</description><dc:title>Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis</dc:title><dc:creator>Julio Beltrame Daleprane, Vanessa da Silva Freitas, Alejandro Pacheco, Martina Rudnicki, Luciane Aparecida Faine, Felipe Augusto Dörr, Masaharu Ikegaki, Luis Antonio Salazar, Thomas Prates Ong, Dulcinéia Saes Parra Abdalla</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>557</prism:startingPage><prism:endingPage>566</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000878/abstract?rss=yes"><title>Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance</title><link>http://www.jnutbio.com/article/PIIS0955286311000878/abstract?rss=yes</link><description>Abstract: Obesity is an inflammatory condition that is also associated with increased extracellular matrix (ECM) gene expression. However, a direct link between adipose tissue inflammation and ECM gene expression has not been established. Therefore, we determined the effect of chronic inflammation induced by obesity and acute inflammation by lipopolysaccharide (LPS) challenge on ECM genes including biglycan (BGN), collagen 1A1 (COL1A1) and COL6A1, major ECM genes in adipose tissue. Male C57BL/6J mice fed either a control diet (10% fat calories) or a high-fat diet (HFD) (60% fat calories) for 6 weeks were treated with LPS or saline 24 h before sacrifice. Expression of ECM genes in the epididymal (EWAT) and subcutaneous adipose tissue (SWAT) was determined by RT-PCR and protein abundance by Western blotting. Human SWAT from lean and obese subjects was also analyzed. Increased messenger RNA (mRNA) expression of ECM genes BGN and COL1A1 was observed in the mouse EWAT after HFD (P&lt;.05). However, reduced amount of COL1A1 protein was observed in EWAT of mice on HFD and in SWAT from obese human subjects. Acute inflammation induced BGN mRNA in EWAT, enhanced the gene expression of matrix metalloproteases (MMPs) 3 and 9. Acute inflammation also resulted in higher MMP9 gelatinolytic activity; however, this showed no association with COL1A1 protein abundance. Higher MMP2 expression in mice on HFD suggests its involvement in the reduction of COL1A1 protein abundance with HFD. Elevated MMP9 gelatinolytic activity in SWAT from obese humans indicates a prominent role for MMP9 in SWAT COL1A1 protein turnover in humans.</description><dc:title>Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance</dc:title><dc:creator>Venkata J. Adapala, Sunday A. Adedokun, Robert V. Considine, Kolapo M. Ajuwon</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>567</prism:startingPage><prism:endingPage>572</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631100088X/abstract?rss=yes"><title>Equol production changes over time in postmenopausal women</title><link>http://www.jnutbio.com/article/PIIS095528631100088X/abstract?rss=yes</link><description>Abstract: Equol (EQ) is produced by intestinal bacteria from the soy isoflavone daidzein (DE) in 30%–60% of the population and is believed to provide benefits from soy intake. A robust EQ status definition is lacking, and it is uncertain whether EQ is formed consistently within an individual and ceases upon oral antibiotic treatment.In a randomized, double-blind, placebo-controlled soy intervention trial with 350 postmenopausal women, DE and EQ were analyzed by liquid chromatography/tandem mass spectrometry at baseline and every 6 months over 2.5 years in overnight urine, spot urine and plasma. Equol production changes and status (remaining an EQ producer or nonproducer or changing towards an EQ producer or nonproducer) were assessed.Equol status was determined most dependably by overnight urine applying as cutoff a ratio of EQ/DE≥0.018 with a DE threshold ≥2 nmol/mg creatinine: the soy and placebo groups had approximately 30% consistent EQ producers during the study, but 14% and 35%, respectively, changed EQ status (mean 1.4–1.7 times), while 27% and 17%, respectively, had antibiotic treatment (P&lt;.01 for inverse association). No significant trend in change of EQ production or status was observed when overnight urine was limited to collections closest to before and after antibiotic treatment. Similarly, antibiotic type or class, duration, dose or time between antibiotic treatment and overnight urine collection showed no consistent influence on EQ production.Equol production can markedly change intraindividually over 2.5 years, and antibiotic treatment impacts it inconsistently. Factors other than antibiotic treatment must be considered as causes for EQ production changes.</description><dc:title>Equol production changes over time in postmenopausal women</dc:title><dc:creator>Adrian A. Franke, Jennifer F. Lai, Brunhild M. Halm, Ian Pagano, Naoko Kono, Wendy J. Mack, Howard N. Hodis</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>573</prism:startingPage><prism:endingPage>579</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000891/abstract?rss=yes"><title>Trans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytes</title><link>http://www.jnutbio.com/article/PIIS0955286311000891/abstract?rss=yes</link><description>Abstract: Conjugated linoleic acid (CLA) reduces adiposity in vivo. However, mechanisms mediating these changes are unclear. Therefore, we treated cultures of human adipocytes with trans-10, cis-12 (10,12) CLA, cis-9, trans-11 (9,11) CLA or other trans fatty acids (FA), and measured indices of lipid metabolism. The lipid-lowering effects of 10,12 CLA were unique, as other trans FA did not reduce TG content to the same extent. Using low levels of [14C]-CLA isomers, it was shown that both isomers were readily incorporated into acylglycerols and phospholipids, albeit at lower levels than [14C]-oleic or [14C]-linoleic acids. When using [14C]-acetic acid and [14C]-pyruvic acid as substrates, 30 μM 10,12 CLA, but not 9,11 CLA, decreased de novo synthesis of triglyceride, free FA, diacylglycerol, cholesterol esters, cardiolipin, phospholipids and ceramides within 3–24 h. Treatment with 30 μM 10,12 CLA, but not 9,11 CLA, decreased total cellular lipids within 3 days and the ratio of monounsaturated FA (MUFA) to saturated FA, and increased C18:0 acyl-CoA levels within 24 h. Consistent with these data, stearoyl-CoA desaturase (SCD)-1 mRNA and protein levels were down-regulated by 10,12 CLA within 7–12 h, respectively. The mRNA levels of liver X receptor (LXR)α and sterol regulatory element binding protein (SREBP)-1c, transcription factors that regulate SCD-1, were decreased by 10,12 CLA within 5 h. These data suggest that the isomer-specific decrease in de novo lipid synthesis by 10,12 CLA is due, in part, to the rapid repression of lipogenic transcription factors that regulate MUFA synthesis, suggesting an anti-obesity mechanism unique to this trans FA.</description><dc:title>Trans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytes</dc:title><dc:creator>Thomas Obsen, Nils J. Faergeman, Soonkyu Chung, Kristina Martinez, Semone Gobern, Olivier Loreau, Martin Wabitsch, Susanne Mandrup, Michael McIntosh</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.014</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>580</prism:startingPage><prism:endingPage>590</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000908/abstract?rss=yes"><title>The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma</title><link>http://www.jnutbio.com/article/PIIS0955286311000908/abstract?rss=yes</link><description>Abstract: Previous studies suggested that curcumin is a potential agent against glioblastomas (GBMs). However, the in vivo efficacy of curcumin in gliomas remains not established. In this work, we examined the mechanisms underlying apoptosis, selectivity, efficacy and safety of curcumin from in vitro (U138MG, U87, U373 and C6 cell lines) and in vivo (C6 implants) models of GBM. In vitro, curcumin markedly inhibited proliferation and migration and induced cell death in liquid and soft agar models of GBM growth. Curcumin effects occurred irrespective of the p53 and PTEN mutational status of the cells. Interestingly, curcumin did not affect viability of primary astrocytes, suggesting that curcumin selectivity targeted transformed cells. In U138MG and C6 cells, curcumin decreased the constitutive activation of PI3K/Akt and NFkappaB survival pathways, down-regulated the antiapoptotic NFkappaB-regulated protein bcl-xl and induced mitochondrial dysfunction as a prelude to apoptosis. Cells developed an early G2/M cell cycle arrest followed by sub-G1 apoptosis and apoptotic bodies formation. Caspase-3 activation occurred in the p53-normal cell type C6, but not in the p53-mutant U138MG. Besides its apoptotic effect, curcumin also synergized with the chemotherapeutics cisplatin and doxorubicin to enhance GBM cells death. In C6-implanted rats, intraperitoneal curcumin (50 mg kg−1 d−1) decreased brain tumors in 9/11 (81.8%) animals against 0/11 (0%) in the vehicle-treated group. Importantly, no evidence of tissue (transaminases, creatinine and alkaline phosphatase), metabolic (cholesterol and glucose), oxidative or hematological toxicity was observed. In summary, data presented here suggest curcumin as a potential agent for therapy of GBMs.</description><dc:title>The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma</dc:title><dc:creator>Alfeu Zanotto-Filho, Elizandra Braganhol, Maria Isabel Edelweiss, Guilherme A. Behr, Rafael Zanin, Rafael Schröder, André Simões-Pires, Ana Maria Oliveira Battastini, José Cláudio Fonseca Moreira</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.015</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>591</prism:startingPage><prism:endingPage>601</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631100091X/abstract?rss=yes"><title>Vitamin E forms inhibit IL-13/STAT6-induced eotaxin-3 secretion by up-regulation of PAR4, an endogenous inhibitor of atypical PKC in human lung epithelial cells</title><link>http://www.jnutbio.com/article/PIIS095528631100091X/abstract?rss=yes</link><description>Abstract: Eotaxin-3 (CCL-26), a potent chemokine for eosinophil recruitment and contributing significantly to the pathogenesis of asthma, is secreted by lung epithelial cells in response to T helper 2 cytokines including interleukin 13 (IL-13). Here we showed that vitamin E forms, but not their metabolites, differentially inhibited IL-13-stimulated generation of eotaxin-3 in human lung epithelial A549 cells. The relative inhibitory potency was γ-tocotrienol (γ-TE) (IC50 ∼15 μM)&gt;γ-tocopherol, δ-tocopherol (IC50 ∼25–50 μM)&gt;α-tocopherol. Consistent with suppression of eotaxin, γ-TE treatment impaired IL-13-induced phosphorylation of STAT6, the key transcription factor for activation of eotaxin expression, and consequently blocked IL-13-stimulated DNA-binding activity of STAT6. In search of the upstream target of γTE by using inhibitor and siRNA approaches, we discovered that the atypical protein kinase C (aPKC) signaling, instead of classical PKC, p38 MAPK, JNK or ERK, played a critical role in IL-13-stimulated eotaxin generation and STAT6 activation. While showing no obvious effect on aPKC expression or phosphorylation, γ-TE treatment resulted in increased expression of prostate-apoptosis-response 4 (PAR4), an endogenous negative regulator of aPKCs. Importantly, γ-TE treatment led to enhanced formation of aPKC/PAR4 complex that is known to reduce aPKC activity via protein–protein crosstalk. Our study demonstrated that γ-TE inhibited IL-13/STAT6-activated eotaxin secretion via up-regulation of PAR4 expression and enhancement of aPKC–PAR4 complex formation. These results support the notion that specific vitamin E forms may be useful anti-asthmatic agents.</description><dc:title>Vitamin E forms inhibit IL-13/STAT6-induced eotaxin-3 secretion by up-regulation of PAR4, an endogenous inhibitor of atypical PKC in human lung epithelial cells</dc:title><dc:creator>Yun Wang, Michelle Moreland, James G. Wagner, Bruce N. Ames, Beate Illek, David B. Peden, Qing Jiang</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>602</prism:startingPage><prism:endingPage>608</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000921/abstract?rss=yes"><title>A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome</title><link>http://www.jnutbio.com/article/PIIS0955286311000921/abstract?rss=yes</link><description>Abstract: Thirty-five women with metabolic syndrome and high plasma low-density lipoprotein (LDL) cholesterol (≥100 mg/dl) participated in a dietary intervention consisting of a Mediterranean-style low-glycemic-load diet for 12 weeks. Participants were randomly allocated to consume diet only (n=15) or diet plus a medical food containing soy protein and plant sterols (n=20). Plasma concentrations of carotenoids, lipoprotein subfractions and oxidized LDL (OxLDL) were measured. Independent of treatment, women had a significant increase in plasma lutein (P&lt;.0001) and β-carotene (P&lt;.0001), while plasma lycopene was reduced (P&lt;.05) after 12 weeks. Low-density lipoprotein cholesterol was reduced from 138±35 to 114±33 mg/dl (P&lt;.0001). In addition, decreases were observed in the atherogenic subfractions: large very low-density lipoprotein (P&lt;.05), small LDL (P&lt;.00001) and medium high-density lipoprotein (P&lt;.05). Oxidized LDL was significantly reduced by 12% in both groups (P&lt;.01). Changes in OxLDL were inversely correlated with plasma lutein (r=-.478, P&lt;.0001). The data indicate that women complied with the dietary regimen by increasing fruits and vegetable intake. Decreased consumption of high-glycemic foods frequently co-consumed with lycopene-rich tomato sauce such as pasta and pizza may be responsible for the lowering of this carotenoid in plasma after 12 weeks. These results also suggest that plasma lutein concentrations may protect against oxidative stress by reducing the concentrations of OxLDL.</description><dc:title>A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome</dc:title><dc:creator>Jacqueline Barona, Jennifer J. Jones, Rachel E. Kopec, Michael Comperatore, Catherine Andersen, Steven J. Schwartz, Robert H. Lerman, Maria Luz Fernandez</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.02.016</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>609</prism:startingPage><prism:endingPage>615</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000933/abstract?rss=yes"><title>Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men</title><link>http://www.jnutbio.com/article/PIIS0955286311000933/abstract?rss=yes</link><description>Abstract: Our previous study with docosahexaenoic acid (DHA) supplementation to hypertriglyceridemic men showed that DHA reduced several risk factors for cardiovascular disease, including the plasma concentration of inflammatory markers. To determine the effect of DHA supplementation on the global gene expression pattern, we performed Affymetrix GeneChip microarray analysis of blood cells [treated with lipopolysaccharide (LPS) or vehicle] drawn before and after the supplementation of DHA from the hypertriglyceridemic men who participated in that study. Genes that were significantly differentially regulated by the LPS treatment and DHA supplementation were identified. Differential regulation of 18 genes was then verified by quantitative real-time polymerase chain reaction (qRT-PCR). Both microarray and qRT-PCR data showed that DHA supplementation significantly suppressed the expression of low-density lipoprotein (LDL) receptor and cathepsin L1, both of which were also up-regulated by LPS. DHA supplementation also suppressed oxidized LDL (lectin-like) receptor 1 (OLR1). However, LPS did not induce OLR1 mRNA expression. Enrichment with Gene Ontology categories demonstrated that the genes related to transcription factor activity, immunity, host defense and inflammatory responses were inversely regulated by LPS and DHA. These results provide supporting evidence for the anti-inflammatory effects of DHA supplementation, and reveal previously unrecognized genes that are regulated by DHA and are associated with risk factors of cardiovascular diseases.</description><dc:title>Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men</dc:title><dc:creator>Kevin Dawson, Ling Zhao, Yuriko Adkins, Madhuri Vemuri, Raymond L. Rodriguez, Jeffrey P. Gregg, Darshan S. Kelley, Daniel H. Hwang</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>616</prism:startingPage><prism:endingPage>621</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000945/abstract?rss=yes"><title>Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice</title><link>http://www.jnutbio.com/article/PIIS0955286311000945/abstract?rss=yes</link><description>Abstract: MicroRNAs modulate processes associated with cell cycle control and differentiation. Here we explored the potential of microRNAs in the modulation of hepatic lipid metabolism and the development of nonalcoholic fatty liver disease.MicroRNA profiles of hepatocytes from low-density lipoprotein (LDL) receptor knockout mice fed a chow diet or a hypertriglyceridemia/fatty liver-inducing Western-type diet (WTD) were determined using quantitative real-time polymerase chain reaction. Ninety-seven of 103 microRNAs measured were expressed by hepatocytes and low variability between hepatocyte pools was observed. Feeding WTD coincided with a marked fivefold decrease in the relative expression level of miR-216 (P&lt;.05) and miR-302a (P&lt;.01). Interestingly, an increased hepatic miR-216 expression was detected in response to fasting. MicroRNA/biological function linkage analysis suggested that the change in hepatocyte microRNA profiles in response to high dietary lipid levels is associated with changes in cell cycle control and proliferation. In accordance with a diminished miR-302a expression on the WTD, hepatocyte mRNA expression levels of miR-302a target genes ABCA1 and in particular ELOVL6 were increased in response to WTD (twofold to ninefold). This suggests a role for miR-302a in hepatic cholesterol, fatty acid and glucose metabolism.In conclusion, we have shown that fatty liver development in LDL receptor knockout mice is associated with a significant change in the hepatocyte microRNA profile, i.e., a fivefold decrease in miR-216 and miR-302a expression. Based upon our comparative gene and microRNA expression studies it is anticipated that miR-302a may prove to be a valuable therapeutic target in the regulation of hepatic fatty acid utilization and insulin resistance.</description><dc:title>Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice</dc:title><dc:creator>Menno Hoekstra, Ronald J. van der Sluis, Johan Kuiper, Theo J.C. Van Berkel</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>622</prism:startingPage><prism:endingPage>628</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000957/abstract?rss=yes"><title>The effects of transformation and ZnT-1 silencing on zinc homeostasis in cultured cells</title><link>http://www.jnutbio.com/article/PIIS0955286311000957/abstract?rss=yes</link><description>Abstract: We have previously demonstrated that reducing the availability of zinc with the extracellular chelator diethylenetriaminepentaacetic acid (DTPA) promotes efflux of 65Zn from rat primary hepatocytes and pituitary cells, but increases retention of label in rat hepatoma (H4IIE) and anterior pituitary tumor (GH3) cell lines. To further understand this differential response between primary cells and the corresponding cancer cell lines, we investigated the effects of immortalizing primary cells on their zinc homeostasis. Rat primary hepatocytes were electroporated with the SV40 large T-antigen-coding plasmid pSV3-neo and selected for neomycin resistance. This resulted in cell division of the normally quiescent hepatocytes. When these cells were prelabeled with 65Zn, DTPA decreased efflux of 65Zn, similarly to hepatoma cells and differently from primary hepatocytes. This homeostatic change may be required to account for the greater zinc requirements of dividing cells and be mediated by alterations in the activity of zinc transporter ZnT-1, which is responsible for zinc efflux. To further understand the mechanism of DTPA-induced zinc retention, we down-regulated the expression of ZnT-1 in rat hepatoma cells using vector-based short hairpin RNA interference. Expression of ZnT-1 protein was reduced to approximately 50%. Down-regulation of ZnT-1 resulted in greater retention of 65Zn in control cells. However, DTPA increased rather than decreased efflux of label from knockdown cells, suggesting that functional ZnT-1 is required for the decreased efflux in response to DTPA. We conclude that ZnT-1 expression is crucial for maintaining zinc homeostasis, in particular, for the enhanced retention of zinc in transformed cells when subjected to zinc deprivation.</description><dc:title>The effects of transformation and ZnT-1 silencing on zinc homeostasis in cultured cells</dc:title><dc:creator>Kavitha Sankavaram, Hedley C. Freake</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>629</prism:startingPage><prism:endingPage>634</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000969/abstract?rss=yes"><title>Cytosine methylation in miR-153 gene promoters increases the expression of holocarboxylase synthetase, thereby increasing the abundance of histone H4 biotinylation marks in HEK-293 human kidney cells</title><link>http://www.jnutbio.com/article/PIIS0955286311000969/abstract?rss=yes</link><description>Abstract: Holocarboxylase synthetase (HCS) plays an essential role in catalyzing the biotinylation of carboxylases and histones. Biotinylated carboxylases are important for the metabolism of glucose, lipids and leucine; biotinylation of histones plays important roles in gene regulation and genome stability. Recently, we reported that HCS activity is partly regulated by subcellular translocation events and by miR-539. Here we tested the hypothesis that the HCS 3′-untranslated region (3′-UTR) contains binding sites for miR other than miR-539. A binding site for miR-153 was predicted to reside in the HCS 3′-UTR by using in silico analyses. When miR-153 site was overexpressed in transgenic HEK-293 human embryonic kidney cells, the abundance of HCS mRNA decreased by 77% compared with controls. In silico analyses also predicted three putative cytosine methylation sites in two miR-153 genes; the existence of these sites was confirmed by methylation-sensitive polymerase chain reaction. When cytosines were demethylated by treatment with 5-aza-2′-deoxycytidine, the abundance of miR-153 increased by more than 25 times compared with untreated controls, and this increase coincided with low levels of HCS and histone biotinylation. Together, this study provides novel insights into the mechanisms of novel epigenetic synergies among folate-dependent methylation events, miR and histone biotinylation.</description><dc:title>Cytosine methylation in miR-153 gene promoters increases the expression of holocarboxylase synthetase, thereby increasing the abundance of histone H4 biotinylation marks in HEK-293 human kidney cells</dc:title><dc:creator>Baolong Bao, Rocio Rodriguez-Melendez, Janos Zempleni</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>635</prism:startingPage><prism:endingPage>639</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000970/abstract?rss=yes"><title>Continuous intake of a high-fat diet beyond one generation promotes lipid accumulation in liver and white adipose tissue of female mice</title><link>http://www.jnutbio.com/article/PIIS0955286311000970/abstract?rss=yes</link><description>Abstract: Lipid metabolism in a child may be altered when the mother has a high-fat diet (HFD), but it is unclear whether the lipid metabolism of future offspring (grandchildren) is also changed under these circumstances. In this study, we examined the influence of intake of an HFD beyond one generation on offspring in normal mice. Parent mice fed an HFD were bred and the resultant second and third generations were also fed an HFD. The diets used in the study had approximately 20% more energy than a standard chow diet. Changes in lipid metabolism were examined in each generation. Intake of an HFD from generation to generation promoted lipid accumulation in the white adipose tissue of female mice, increased lipid, glucose and insulin levels in the serum, increased the activities of enzymes associated with fatty acid metabolism in the liver, promoted lipid accumulation in hepatocytes and adipocytes and increased the mRNA levels of Cdkn1a in the liver and white adipose tissue. These results suggest that activation of Cdkn1a promoted lipid accumulation in the liver and white adipose tissue of third-generation female mice that were offspring from earlier generations fed HFDs. Moreover, intake of a high-energy diet beyond one generation led to offspring with obesity, fatty liver and hyperinsulinemia.</description><dc:title>Continuous intake of a high-fat diet beyond one generation promotes lipid accumulation in liver and white adipose tissue of female mice</dc:title><dc:creator>Mariko Takasaki, Taro Honma, Miyuki Yanaka, Kenta Sato, Nahoko Shinohara, Junya Ito, Yurie Tanaka, Tsuyoshi Tsuduki, Ikuo Ikeda</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-20</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-20</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>640</prism:startingPage><prism:endingPage>645</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000982/abstract?rss=yes"><title>Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells</title><link>http://www.jnutbio.com/article/PIIS0955286311000982/abstract?rss=yes</link><description>Abstract: Capsaicin is a pungent ingredient in chili red peppers and has been linked to suppression of growth in various cancer cells. However, the underlying mechanism(s) by which capsaicin induces growth arrest and apoptosis of cancer cells is not completely understood. In the present study, we investigated whether capsaicin alters β-catenin-dependent signaling in human colorectal cancer cells in vitro. Exposure of SW480, LoVo and HCT-116 cells to capsaicin suppressed cell proliferation. Transient transfection with a β-catenin/T-cell factor (TCF)-responsive reporter indicated that capsaicin suppressed the transcriptional activity of β-catenin/TCF. Capsaicin treatment resulted in a decrease of intracellular β-catenin levels and a reduction of transcripts from the β-catenin gene (CTNNB1). These results were confirmed by a reduced luciferase reporter activity driven by promoter–reporter construct containing the promoter region of the Catnb gene. In addition, capsaicin destabilized β-catenin through enhancement of proteosomal-dependent degradation. Western blot and immunoprecipitation studies indicated that capsaicin treatment suppressed TCF-4 expression and disrupted the interaction of TCF-4 and β-catenin. This study identifies a role for the β-catenin/TCF-dependent pathway that potentially contributes to the anticancer activity of capsaicin in human colorectal cancer cells.</description><dc:title>Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells</dc:title><dc:creator>Seong-Ho Lee, Raphael L. Richardson, Roderick H. Dashwood, Seung Joon Baek</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-18</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-18</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>646</prism:startingPage><prism:endingPage>655</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311000994/abstract?rss=yes"><title>Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells</title><link>http://www.jnutbio.com/article/PIIS0955286311000994/abstract?rss=yes</link><description>Abstract: Quercetin is a flavonol modifying a number of cell processes in different cell lines. Here, we present evidence that nonconjugated quercetin enters cells possibly via organic anion transporter polypeptides and quickly accumulates in the nucleus where it concentrates at distinct foci. Furthermore, it induces major transcriptional events with a high number of transcripts being modified over time and about 2200 transcripts being continuously influenced by the agent. The latter transcripts are related to cell cycle and adhesion, xenobiotic metabolism, immune-related factors and transcription. In addition, quercetin up-regulates the expression of estrogen receptors α and β. The overall outcome on cell fate is reflected by an inhibition of cell proliferation, cell cycle arrest in the G1 phase and reduction of the cells' migratory potential due to actin cytoskeleton disorganization. Finally, we report that the flavonol modifies the transcription and/or activity of numerous transcription factors. In conclusion, our data support the idea that quercetin may actively accumulate in discrete cell structures and exert more than just antioxidant actions on epithelial cells by regulating mechanisms related to gene transcription.</description><dc:title>Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells</dc:title><dc:creator>George Notas, Artemisia-Phoebe Nifli, Marilena Kampa, Vassiliki Pelekanou, Vasileia-Ismini Alexaki, Panayiotis Theodoropoulos, Joseph Vercauteren, Elias Castanas</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-07-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-07-22</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>656</prism:startingPage><prism:endingPage>666</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311001008/abstract?rss=yes"><title>Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs</title><link>http://www.jnutbio.com/article/PIIS0955286311001008/abstract?rss=yes</link><description>Abstract: Previous studies have shown that an increased intake of dietary flavonoids is associated with a decreased risk of cardiovascular diseases (CVDs). PDGF is a major mitogen for vascular smooth muscle cell (VSMC) and participates in the pathogenesis of many CVDs. The study investigated whether the flavone chrysin affected PDGF functions in VSMCs and neointma formation in rat artery. We found that chrysin concentration-dependently inhibited PDGF-induced proliferation and chemotaxis and reduced PDGF signaling in VSMCs. Chrysin attenuated H2O2 signaling and PDGF-induced reactive oxygen species production and NADPH oxidase activation but did not interfere with PDGF binding to VSMCs. The further analyses revealed that chrysin relieved PDGF-induced inhibition on activity of protein tyrosine phosphatase (PTP) and reduced PDGF-induced oxidation of PTP cysteinyl active site. Moreover, it inhibited PDGF receptor autophosphorylation induced by low-dose vanadate (an inhibitor for PTP). The effect of chrysin, but not of the flavonoid (-)-epigallocatechin-3-gallate and antioxidant N-acetylcysteine, on PDGF signaling and PTP activity was reversed by depletion of intracellular glutathione (GSH), suggesting an involvement of chrysin on GSH/glutaredoxin system for PTP reactivation. Finally, to demonstrate the effectiveness of chrysin in vivo, we showed that oral administration of chrysin before and after angioplasty could reduce neointima formation in balloon-injured carotid artery in rats. In conclusion, we provide here evidence that chrysin can regulate intracellular PTP activity during PDGF signaling, inhibits PDGF-induced VSMC proliferation and chemotaxis, and reduces arterial intima hyperplasia in vivo.</description><dc:title>Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs</dc:title><dc:creator>Huey-Ming Lo, Min-Wen Wu, Shiow-Lin Pan, Chieh-Yu Peng, Pi-Hui Wu, Wen-Bin Wu</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-08-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-08-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>667</prism:startingPage><prism:endingPage>678</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311001136/abstract?rss=yes"><title>Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal</title><link>http://www.jnutbio.com/article/PIIS0955286311001136/abstract?rss=yes</link><description>Abstract: Objective: This investigation attempted to clarify the effects of soy protein on alcoholic liver disease (ALD) in rats undergoing ethanol withdrawal.Methods: Alcoholic liver disease was induced in rats by administration of a low-carbohydrate ethanol liquid diet for 12 weeks, after which the ethanol was withdrawn and the rats were divided into two experimental groups: a control group (EC group) and a soy protein group (EP group) for 4 weeks.Results: After the 12-week ALD-inducing period, the ethanol group had significantly higher hepatic lipid accumulation, oxidative stress and inflammation. We found that the EP group had significantly lower hepatic lipids, malondialdehyde, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, hydroxyproline levels and myeloperoxidase activity compared to the EC group. Moreover, the fecal total cholesterol and total lipids were higher in the EP group. Expression of the hepatic cytochrome P450 2E1 (CYP2E1) protein in the EP group was significantly lower than that in the EC group, and the hepatic peroxisome proliferator-activated receptor (PPAR) α and cytochrome P450 4A (CYP4A) protein expressions in the EP group were significantly higher than those in the EC group. In the histopathological analysis, we also found that soy protein ameliorated fat accumulation in the liver.Conclusion: These results suggest that soy protein may improve alcohol-induced lipid accumulation, oxidative stress and inflammation by decreasing proinflammatory cytokines and CYP2E1 protein expression and by increasing PPARα and CYP4A protein expressions and fecal lipid excretion, thereby producing beneficial effects on ALD during ethanol withdrawal.</description><dc:title>Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal</dc:title><dc:creator>Hsin-Yi Yang, Hsiao-Shan Lin, Jane C.J. Chao, Yi-Wen Chien, Hsiang-Chi Peng, Jiun-Rong Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.016</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-08-03</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-08-03</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>679</prism:startingPage><prism:endingPage>684</prism:endingPage></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286311001240/abstract?rss=yes"><title>Linoleic acid increases monocyte chemotaxis and adhesion to human aortic endothelial cells through protein kinase C- and cyclooxygenase-2-dependent mechanisms</title><link>http://www.jnutbio.com/article/PIIS0955286311001240/abstract?rss=yes</link><description>Abstract: The effects of polyunsaturated n-6 linoleic acid on monocyte–endothelial interactions were investigated with particular emphasis on the expression of platelet/endothelial cell adhesion molecule (PECAM)-1 and the role of protein kinase C (PKC) and cyclooxygenase-2 (COX-2). As a diet rich in polyunsaturated fatty acids may favour atherosclerosis in hyperglycaemia, this study was performed in both normal and high-glucose media using human aortic endothelial cells (HAEC). The HAEC were preincubated with normal (5 mM) or high (25 mM) d-glucose for 3 days before addition of fatty acids (0.2 mM) for 3 days. Linoleic acid enhanced PECAM-1 expression independently of tumor necrosis factor (TNF)-α and significantly increased TNF-α-induced monocyte adhesion to HAEC in comparison to the monounsaturated n-9 oleic acid. Chronic glucose treatment (25 mM, 6 days) did not modify the TNF-α-induced or fatty acid-induced changes in monocyte binding. The increase in monocyte binding was accompanied by a significant increase in E-selectin and vascular cell adhesion molecule (VCAM)-1 expression and could be abrogated by an interleukin (IL)-8 neutralising antibody and by the PKC and COX inhibitors. Inhibition of PKC-δ reduced VCAM-1 expression regardless of experimental condition and was accompanied by a significant decrease in monocyte binding. Conditioned medium from linoleic acid-treated HAEC grown in normal glucose conditions significantly increased THP-1 chemotaxis. These results suggest that linoleic acid-induced changes in monocyte chemotaxis and subsequent binding are not solely mediated by changes in adhesion molecule expression but may be due to secreted factors such as IL-8, monocyte chemoattractant protein-1 or prostaglandins (PGs) such as PGE2, as IL-8 neutralisation and COX-2 inhibition reduced monocyte binding without changes in adhesion molecule expression.</description><dc:title>Linoleic acid increases monocyte chemotaxis and adhesion to human aortic endothelial cells through protein kinase C- and cyclooxygenase-2-dependent mechanisms</dc:title><dc:creator>Nuria Matesanz, Victoria Jewhurst, Elisabeth R. Trimble, Ann McGinty, Daphne Owens, Gerald H. Tomkin, Lesley A. Powell</dc:creator><dc:identifier>10.1016/j.jnutbio.2011.03.020</dc:identifier><dc:source>The Journal of Nutritional Biochemistry 23, 6 (2012)</dc:source><dc:date>2011-08-16</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2011-08-16</prism:publicationDate><prism:volume>23</prism:volume><prism:number>6</prism:number><prism:issueIdentifier>S0955-2863(12)X0005-6</prism:issueIdentifier><prism:section>Research Articles</prism:section><prism:startingPage>685</prism:startingPage><prism:endingPage>690</prism:endingPage></item></rdf:RDF>
